Alpha-1 Antitrypsin Deficiency (AATD) Thought Leader Liaison (TLL)- California

Role Summary

This is a remote/field, field-based commercial role as the Alpha-1 Antitrypsin Deficiency (AATD) Thought Leader Liaison (TLL) within Sanofi's US organization. The TLL engages key opinion leaders, healthcare professionals, and patient advocacy groups to provide education, coordinate HCP peer‑to‑peer and patient programs, and gather insights to inform commercial strategy and execution. The role requires extensive knowledge of the AATD landscape and strict compliance with pharma, field, and HQ protocols, while collaborating across internal teams to ensure a One Sanofi approach. At launch, the role is expected to transition into an HCP-facing Sales role with quarterly incentive eligibility.

Responsibilities

• Uses segmentation to engage KOLs, HCPs, and patients per SOPs
• Aligns closely with HCP/account and patient marketing teams and patient advocacy organizations to compliantly engage HCP and patient communities
• Serves as a single point of contact to resolve stakeholder issues related to education programs
• Coordinates outreach to KOLs, HCPs, and PAGs to deliver HCP P2P and patient programs
• Plans and executes HCP P2P programs: in-office events, conferences/congresses, and webinars
• Plans and executes patient educational programs: lunch/dinner programs, conferences/congresses, and webinars, in partnership with approved vendors and advocacy groups
• Leads planning, execution, and pull-through of in-practice programs; manages logistics, invitations, attendance, and follow-up
• Facilitates cross-functional planning, recruitment, and execution of regional/national advisory boards; capture and report feedback
• Provides competitive and market intelligence derived from compliant interactions
• Reviews approved marketing content with currently contracted speakers; contributes to the identification and nomination of future speakers
• Attends programs to observe, coach, and remediate as needed for compliant execution
• Partners with HQ to provide input to content, and to reflect updated materials in ongoing programs
• Manages reporting on program KPIs and field execution; optimize scheduling and utilization of high-volume speakers/ambassadors
• Plans and executes stakeholder engagements and executive encounters at local, regional, and national congresses, webinars, and field visits
• Adheres to all company policies, SOPs, PhRMA Code, OIG guidance, and privacy requirements related to HCP and patient interactions
• Ensures appropriate approvals and documentation for all programs, materials, and consultants

Qualifications

• Experience in pulmonology/rare respiratory disease, launches, rare communities, strongly preferred
• Strong network development abilities, with a track record of establishing connections, referrals, and infrastructure for key accounts
• Established understanding of pulmonologists, primary care physicians, allergists/immunologists, and care teams requested
• Minimum 5 years in at least one of: HCP education, patient education, KOL engagement, patient advocacy group (PAG) engagement
• Sales experience with proven results (preferably in the pharmaceutical or healthcare industry, with a focus on rare diseases or specialized therapeutic areas preferred)
• Demonstrated success executing HCP peer-to-peer (P2P) and patient programs (live and virtual) with strong project management and logistics skills
• Practice developing and executing meetings, training, programs, as well as strategic and tactical plans
• Familiarity with AATD care pathways (e.g., diagnosis, genetic testing, multidisciplinary management) preferred
• Proven leadership, executive presence, and cross-functional collaboration skills
• Excellent communication and presentation abilities; strong organization and analytical planning
• Ability to manage multiple projects under tight timelines; proficiency with CRM and reporting tools

Education

• Bachelor’s degree required

Additional Requirements

• Must reside within the geographic area of the assigned territory, or within a reasonable distance as determined by leadership
• Ability to travel 60-80%; could be less depending on geography
• STI only (pre-launch); IC eligible (at launch), as Sanofi expects this role to transition into an HCP-facing Sales role